User profiles for Toshihiro Shirai
Toshihiro ShiraiShizuoka General Hospital Verified email at i.shizuoka-pho.jp Cited by 3576 |
[HTML][HTML] Prognostic factors for myositis-associated interstitial lung disease
…, K Yokomura, N Koshimizu, M Toyoshima, T Shirai… - PLoS one, 2014 - journals.plos.org
Background Interstitial lung disease (ILD) is a common manifestation of polymyositis (PM),
dermatomyositis (DM), and clinically amyopathic dermatomyositis (CADM); however, little is …
dermatomyositis (DM), and clinically amyopathic dermatomyositis (CADM); however, little is …
Alterations in smoking habits are associated with acute eosinophilic pneumonia
Background Acute eosinophilic pneumonia (AEP) is characterized by a febrile illness, diffuse
pulmonary infiltrates, and pulmonary eosinophilia. The etiology of AEP remains unknown, …
pulmonary infiltrates, and pulmonary eosinophilia. The etiology of AEP remains unknown, …
Clinical application of the forced oscillation technique
T Shirai, H Kurosawa - Internal Medicine, 2016 - jstage.jst.go.jp
The forced oscillation technique (FOT) is a noninvasive method with which to measure
respiratory system resistance and reactance during tidal breathing. Recently, its clinical …
respiratory system resistance and reactance during tidal breathing. Recently, its clinical …
Efficacy of Clarithromycin and Ethambutol for Mycobacterium avium Complex Pulmonary Disease. A Preliminary Study
S Miwa, M Shirai, M Toyoshima, T Shirai… - Annals of the …, 2014 - atsjournals.org
Rationale: Patients with Mycobacterium avium complex pulmonary disease are frequently
administered a combination of clarithromycin, ethambutol, and rifampicin. However, rifampicin …
administered a combination of clarithromycin, ethambutol, and rifampicin. However, rifampicin …
Serum indoleamine 2, 3-dioxygenase activity predicts prognosis of pulmonary tuberculosis
…, Y Nakamura, N Inui, T Shirai… - Clinical and Vaccine …, 2012 - Am Soc Microbiol
Tuberculosis (TB) continues to be a major health problem, and there are few biomarkers for
predicting prognosis. Indoleamine 2,3-dioxygenase (IDO), a potent immunoregulatory …
predicting prognosis. Indoleamine 2,3-dioxygenase (IDO), a potent immunoregulatory …
[HTML][HTML] Clinical diagnosis of idiopathic pleuroparenchymal fibroelastosis: a retrospective multicenter study
…, M Toyoshima, S Imokawa, T Yamada, T Shirai… - Respiratory …, 2017 - Elsevier
Background Although the accurate diagnosis of pleuroparenchymal fibroelastosis (PPFE)
requires pathologic evaluation, this diagnosis is often suggested when the radiologic findings …
requires pathologic evaluation, this diagnosis is often suggested when the radiologic findings …
Effect of pet removal on pet allergic asthma
T Shirai, T Matsui, K Suzuki, K Chida - Chest, 2005 - Elsevier
Background Allergen avoidance has been recommended in the management of allergic
asthma. Very few studies have assessed the effect of pet removal on pet allergic asthma. …
asthma. Very few studies have assessed the effect of pet removal on pet allergic asthma. …
[HTML][HTML] Rheumatoid lung disease: prognostic analysis of 54 biopsy-proven cases
…, T Fujisawa, N Inui, S Imokawa, K Yasuda, T Shirai… - Respiratory …, 2012 - Elsevier
OBJECTIVE: To investigate the prognostic significance of histopathological characteristics in
patients with biopsy-proven rheumatoid lung disease (RLD). MATERIALS AND METHODS: …
patients with biopsy-proven rheumatoid lung disease (RLD). MATERIALS AND METHODS: …
[HTML][HTML] Macrophage mannose receptor, CD206, predict prognosis in patients with pulmonary tuberculosis
Y Suzuki, M Shirai, K Asada, H Yasui, M Karayama… - Scientific reports, 2018 - nature.com
Tuberculosis (TB) remains a leading cause of fatal infectious disease. Accumulations of
macrophages are found in infected sites; thus, we hypothesized that a marker of activated …
macrophages are found in infected sites; thus, we hypothesized that a marker of activated …
Relationship of the asthma control test with pulmonary function and exhaled nitric oxide
BACKGROUND: The Asthma Control Test (ACT) is a short, simple, patient-based tool for
identifying patients with poorly controlled asthma; however, its value in practice has yet to be …
identifying patients with poorly controlled asthma; however, its value in practice has yet to be …